inhibit, HIV, HIV Protease, HIVProtease, HIV-2, HIV-1, Inhibitor, Human immunodeficiency virus, CCR2, CCR, Cenicriviroc, CCR5, CC chemokine receptor, TAK 652, TAK652, TAK-652, TBR 652, TBR652, TBR-652
Cenicriviroc (TAK-652) is an orally bioavailable dual CCR2 and CCR5 antagonist. It exhibits anti-HIV-1/2 activity and has been investigated in research for its anti-inflammatory effects in models of liver and kidney fibrosis, both in vitro and in vivo.